Related Experiment Video

Updated: Mar 20, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K

A Cost-Effectiveness Evaluation for a New Therapy in HIV Treatment

S Malhan1, G Kockaya2, T Elbir Zengin2

  • 1Baskent University, Ankara, Turkey.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 21, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.3K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K

Related Experiment Videos

Last Updated: Mar 20, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.3K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.4K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

318
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
318

Articles linked to this work by shared authors, journal, and citation graph.

Cardiac thrombus: can T1 and T2 mapping replace contrast enhanced images?

Clinical radiology·2025

Antibiotic management programme in a tertiary intensive care unit: effects of a carbapenem-restricted period on clinical and laboratory parameters and costs of infections.

The Journal of hospital infection·2024

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2023

Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors.

JTO clinical and research reports·2023

Anxiety level and clinical course of patients with sickle cell disease during the COVID-19 outbreak.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2021

Economic burden of severe asthma in Turkey: a cost of illness study from payer perspective.

European annals of allergy and clinical immunology·2020

Cost-effectiveness of opportunistic salpingectomy during various non-gynecological abdominal surgeries for the prevention of tubo-ovarian carcinoma: results from a Markov Modelling study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Super Learner G-Computation as a Model-Specification Sensitivity Analysis for Population-Adjusted Indirect Comparisons in Health Technology Assessment.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Therapeutic Drug Monitoring guided vedolizumab treatment in ulcerative colitis in Cyprus: a cost-effectiveness analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Mapping treatment effects on generic health-related quality of life scales from disease-specific measures using bivariate meta-analytic models and summary data.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Measuring cause-specific tolerance for health inequalities using the social marginal rate of substitution.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Comparative Risk of Respiratory Virus Infections Among Patients with Asthma Treated with Biologic Therapies.

QJM : monthly journal of the Association of Physicians·2026

Biomarker-Guided Management in Vitreoretinal Diseases: Integrating Imaging, Pharmacotherapy, and Surgical Decision-Making-A Narrative Review.

Retina (Philadelphia, Pa.)·2026

Week 96 resistance analysis in participants receiving bictegravir/lenacapavir in the phase 2 ARTISTRY-1 study.

Antiviral therapy·2026

Industry updates in advanced therapy medicinal products and regenerative medicine - July 2026.

Regenerative medicine·2026

In Regulatory First, Myeloma Drug Approved Based on MRD Negativity.

Cancer discovery·2026

Structure and allostery in major facilitator superfamily symport mechanisms.

Acta crystallographica. Section D, Structural biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us